Medical University of South Carolina: Alcoholism trials

The registry lists 44 Alcoholism studies with Medical University of South Carolina as lead sponsor. 4 are open to participants now and 25 have results posted.

Early Phase 1 2Phase 1 6Phase 2 21Phase 3 3Phase 4 7No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• OEA for Young Adults With Alcohol Use DisorderNot yet recruitingNCT07503782Phase 2
• Advancing Couple and Family Alcohol Treatment Through Patient-Oriented Research and MentorshipRecruitingNCT05786157Not applicable
• Brief Family Involved Treatment TelehealthRecruitingNCT05674409Not applicable
• MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive SalienceRecruitingNCT04998916Not applicable
• Wearable Technology and Alcohol-Facilitated Intimate Partner ViolenceCompletedNCT05374798Not applicableResults posted
• Cannabidiol in Youth Alcohol Use DisorderCompletedNCT05317546Phase 2Results posted
• BioWare for AUD and PTSDCompletedNCT05187364Not applicableResults posted
• Oxytocin to Enhance Alcohol Behavioral Couple Therapy (ABCT)CompletedNCT03846505Phase 2Results posted
• Altering Memories That Increase Risk of Relapse in Alcohol Use DisordersCompletedNCT03732248Phase 1Results posted
• N-Acetylcysteine for Adolescent Alcohol Use DisorderCompletedNCT03707951Phase 2Results posted
• Oxytocin and Stress Response in Alcohol Use DisorderCompletedNCT03610633Phase 2Results posted
• Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics AlcoholicsCompletedNCT03220776Phase 2Results posted
• Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)CompletedNCT02966873Phase 2Results posted
• Effects of Cortical Dopamine Regulation on Drinking, Craving, and Cognitive ControlCompletedNCT02949934Phase 2Results posted
• NAC for Treating Comorbid PTSD and SUDCompletedNCT02911285Phase 2Results posted
• Gabapentin for Alcohol Relapse PreventionCompletedNCT02349477Phase 2Results posted
• Oxytocin Suppresses Substance Use Disorders Associated With Chronic StressCompletedNCT02058251Phase 1Results posted
• Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use DisordersCompletedNCT01338506Not applicableResults posted
• Aripiprazole Effects on Alcohol Drinking and CravingCompletedNCT01292057Phase 3Results posted
• Neuromodulation of Trauma Memories in PTSD & Alcohol DependenceCompletedNCT01055171Phase 2Results posted
• Treatment of Alcohol Dependence and Comorbid Bipolar DisorderCompletedNCT01015586Phase 4Results posted
• Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for AlcoholismCompletedNCT00920829Phase 4Results posted
• An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol DependenceCompletedNCT00667875Phase 2Results posted
• Acamprosate vs. Placebo in Bipolar AlcoholicsCompletedNCT00466661Phase 4Results posted
• Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability.CompletedNCT00366626Phase 4Results posted
• Acamprosate in Alcoholics With Comorbid Anxiety or DepressionCompletedNCT00330174Phase 4Results posted
• Prometa Protocol for Alcohol DependenceCompletedNCT00262639Phase 2/3Results posted
• Paroxetine for Comorbid Social Anxiety Disorder and AlcoholismCompletedNCT00246441Phase 4Results posted
• Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone AloneCompletedNCT00183196Phase 3Results posted
• rTMS in Older Adults With MCI and AUDActive, not recruitingNCT05896332Phase 1
• Citicoline in Youth Alcohol Use DisorderActive, not recruitingNCT05870111Phase 2
• Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI OutcomesCompletedNCT04831684Phase 1/2
• Early Intervention Following Sexual AssaultCompletedNCT04582695Not applicable
• Oxytocin to Enhance Integrated Treatment for AUD and PTSDCompletedNCT04523922Phase 2
• Cannabidiol for Alcohol Use DisorderWithdrawnNCT03904849Phase 1/2
• 10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine DependenceCompletedNCT03238859Phase 2
• The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol CuesCompletedNCT02939352Early Phase 1
• Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol CuesCompletedNCT02939313Early Phase 1
• Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSDCompletedNCT01751035Not applicable
• Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical SettingCompletedNCT00862212Not applicable
• Open Label Trial of Acamprosate in Bipolar AlcoholicsCompletedNCT00330486Phase 1/2
• Aripiprazole Effects on Alcohol Reactivity and ConsumptionCompletedNCT00183235Phase 2
• Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and DrinkingCompletedNCT00183222Phase 2
• Behavioral Therapy Plus Naltrexone for AlcoholismCompletedNCT00000456Phase 4